-
Germany identifies far-right suspect in deadly 1970 antisemitic attack
-
Rain delays start of second day's play in England-Pakistan opener
-
PrimeXBT Expands Swap-Free Trading to PXTrader 2.0
-
Russian strikes kill 16 in Kyiv, surrounding region
-
Record number of locations in France top 40C over summer: AFP analysis
-
'It is tough': Indonesia battles wildfires, bracing for worse to come
-
Trump pledges 'economic warfare' on Iran, prompting Tehran derision
-
Seoul detects North Korean missile launches after Trump says to meet Kim
-
'Girl with a Pearl Earring' in Japan, perhaps for the last time
-
Thai, Myanmar military chiefs meet as post-coup thaw progresses
-
Russian strikes kill 13 in Kyiv, surrounding region
-
Asian stocks rally as US Treasury steps in to ease bond fears
-
'Simply lovely': Verstappen signs new Red Bull contract until 2030
-
Verstappen signs new Red Bull contract until 2030: team
-
Australia coach Walters heading to St Helens after World Cup
-
What property giant Evergrande's sentence means for China's economy
-
China jails founder, fines disgraced property giant Evergrande
-
Australian prosecutors demand life in prison for mushroom killer
-
Russian strikes kill 12 in Kyiv, surrounding region
-
Fallout far-reaching for Australian Rules after latest scandal
-
US India ambassador's Kashmir remarks rile Pakistan; envoy summoned
-
Rafts on Rome's Tiber River cool down overheated tourists
-
In Senegal's Saint-Louis, traces of slave-trading past fade away
-
Top seeds Sabalenka, Zverev stunned in Cincinnati fourth round
-
Russian strikes kill 9 in Kyiv, surrounding region
-
Australia says relations with Israel 'difficult' after aid worker death
-
Messi scores first goal since father's death in Miami draw
-
PSG start Ligue 1 defence with eye on Champions League hat-trick
-
Mercedes and Max: What to watch as F1 returns for Dutch GP
-
Arsenal can become world's best club: Arteta
-
'People, not robots': Ukraine's soldiers justify human role amid drone revolution
-
Japan's King Kazu, 59, scores twice from spot to make cup history
-
North Sea drilling tests UK govt climate pledge
-
Kyiv's desperate vendors persevere outside obliterated flea market
-
'Ray of hope': Gaza seed bank rebuilds after wartime destruction
-
Australia races to shield little penguins from H5N1 bird flu
-
Mourinho begins second Real Madrid reign with Barca in his sights
-
Messi scores first goal since father's death
-
'More confrontational': Iran's new hardline security leadership
-
US national debt exceeds $40 trillion for first time
-
UK summons Israeli envoy over West Bank settlement project
-
Brazilian narco violence spills over into tranquil Bolivia
-
Trump vows 'tremendous' economic costs on Iran partners
-
Trump's devoted 'human printer' in media glare
-
Germany, France, UN condemn far-right Israeli minister's 'inhumane' Gaza remarks
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - August 20
-
Great Western Mining Corporation plc Announces Holding(s) in Company
-
HM Exploration Announces DTC Eligibility of Its Common Shares in the United States
-
NuRAN Wireless Announces Investor Relations Agreement With King Tide Media LLC
-
Eagle Plains' Partner Xcite Uranium Inc. Commences Drill Program at the Don Lake Uranium Project, Saskatchewan
New Microbial Testing Lab Expansion at Pace(R) Life Sciences
Expanded microbial limits testing lab in Lebanon, NJ boosts capacity and strengthens analytical services
LEBANON, NJ / ACCESS Newswire / April 2, 2026 / Pace® Life Sciences, a U.S.-based contract development and manufacturing organization (CDMO) and a division of Pace®, a Science and Technology Company announced today the opening of its newly expanded microbial limits testing laboratory at its Lebanon, New Jersey facility, further strengthening the site's comprehensive analytical service offerings.
This upgraded space significantly increases throughput, efficiency, and reliability within an already well‑established microbial limits testing program. With the added capacity, the team can now support higher sample volumes while continuing to uphold the highest standards of quality and regulatory compliance delivering on the organization's ongoing commitment to product quality, patient safety, and operational excellence.
"This expansion is another step forward in enhancing the depth and breadth of services we offer our clients," said Amanda Yoakum, Site Head in Lebanon, NJ. "By investing in both infrastructure and expertise, we are ensuring that our Lebanon facility continues to deliver the speed, scientific rigor, and reliability our partners depend on."
The Lebanon, NJ site is a full-service analytical testing lab that supports a wide range of services, including analytical chemistry, microbiology, sterility testing, container closure integrity testing (CCIT), and packaging and delivery system evaluations. The facility also plays a crucial role in advancing small and large molecule programs from early development through commercialization.
Pace® is a portfolio company of Leonard Green & Partners and Los Angeles-based Aurora Capital Partners.
###
ABOUT PACE® LIFE SCIENCES
Pace® Life Sciences provides a full suite of contract CMC development, clinical trials materials manufacturing, regulatory compliance, consulting, and facility support services to the pharmaceutical, biopharmaceutical, and gene therapy industries. Our network of CDMO sites consists of GMP analytical testing laboratories and manufacturing support service centers. Our experienced, highly trained industry experts and our investment in state-of-the-art development and manufacturing facilities emphasize our commitment to efficiently advancing client programs through the clinic to commercialization. We are dedicated to delivering the best and most reliable services with positive customer experiences across all channels of our business. More at www.pacelifesciences.com.
ABOUT PACE®
Pace® makes the world a safer, healthier place. Pace® people are committed to advancing the science of the pharmaceutical and biotechnology industries in our Life sciences laboratories and supporting businesses, industries, consulting firms, government agencies, and more in our Analytical Services Laboratories. Pace® offers local-level service backed by a national laboratory network. For customers with in-house labs, Pace® provides a range of professional services to keep their operations moving forward. Pace® people work in partnership with customers by providing the service, science and data they need to make critical decisions that benefit us all.
CONTACT:
Chelsea Simpson
Associate Director, Marketing
603.932.3300 | [email protected]
SOURCE: Pace Analytical
View the original press release on ACCESS Newswire
M.King--AT